Bone Graft Clinical Trials

Clinical trials related to Bone Graft Procedure

Radiographical, Histomorphometrical and Biomarker Analysis After Maxillary Sinus Augmentation Utilizing Xenograft Particulate Bone Graft Mixed With Parathyroid Hormone: A Randomized Controlled Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

This study aimed the to investigate the beneficial effect of combining PTH with bovine-derived bone graft bone in maxillary sinus augmentation. There is limited information available about the effect of PTH on maxillary sinus augmentation to achieve a clear understanding of PTH's efficacy in bone regeneration and bone remodelling through radiological, clinical, biomarker, histological and histomorphometric assessment . Objectives 1. Evaluation of the bone density at the planned implants sites using cone beam computed tomography (CBCT). 2. Histomorphometry examination of maxillary sinus bone to measure (bone trabeculae, connective tissue, osteoblast, osteocyte) after healing 4 months after augmentation. 3. Osteopontin as biomarker analysis for bone regeneration and osteoblast activity. 4. Evaluate the primary stability of implant in upper posterior area filled with PTH (1 34) and bovine-derived bone graft compared to bovine-derived bone graft alone.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Healthy individuals without any systemic disease/local pathological lesion at the sinus zone that compromise the bone healing potential.

• Fair to good oral hygiene.

• Patient's age ≥ 18 years.

• The RBH was 3 mm or less. Atrophic edentulous posterior maxillary ridge (missing tooth or teeth in the sinus zone), with adequate ridge width (≥ 5 mm) to accommodate an average DI diameter and to gain primary implant stability.

• Healed planned implant insertion site.

Locations
Other Locations
Iraq
Baghdad University
RECRUITING
Baghdad
Contact Information
Primary
Mohanad Ali Ali Shabat, Msc,PhD student in Oral surgey
mohanadshabat@gmail.com
009647804305996
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2026-11
Participants
Target number of participants: 30
Treatments
Experimental: group I maxillary sinus augmenation with xenograft and PTH
Experimental: group II maxillary sinus augmenation with xenograft alone
Related Therapeutic Areas
Sponsors
Leads: University of Baghdad

This content was sourced from clinicaltrials.gov